Search Results - "Viggers, J.A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    [ 3H]Nisoxetine—A radioligand for noradrenaline reuptake sites: Correlation with inhibition of [ 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments by Cheetham, S.C., Viggers, J.A., Butler, S.A., Prow, M.R., Heal, D.J.

    Published in Neuropharmacology (1996)
    “…Nisoxetine is a potent and selective inhibitor of noradrenaline uptake into noradrenergic neurones. [ 3H]Nisoxetine binding to rat frontal cortical membranes…”
    Get full text
    Journal Article
  2. 2

    [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments by Cheetham, S C, Viggers, J A, Slater, N A, Heal, D J, Buckett, W R

    Published in Neuropharmacology (01-08-1993)
    “…Paroxetine is a selective and potent inhibitor of 5-hydroxytryptamine (5-HT) uptake into serotonergic neurones. [3H]Paroxetine binding to rat frontal cortex…”
    Get more information
    Journal Article
  3. 3

    Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine by Cheetham, S.C, Viggers, J.A, Slater, N.A, Heal, D.J

    Published in Neuropharmacology (01-01-2000)
    “…The effect of sibutramine and dexfenfluramine on 5-HT re-uptake sites, labelled with [ 3H]paroxetine, have been determined in various rat brain regions. In…”
    Get full text
    Journal Article